Long-term effects of angiotensin II blockade with irbesartan on inflammatory markers in hemodialysis patients: A randomized double blind placebo controlled trial (SAFIR study).

Peters, Christian D; Kjaergaard, Krista D; Nielsen, Claus H; Christensen, Kent L; Bibby, Bo M; Jensen, Jens D; Jespersen, Bente

Peters, Christian D; Kjaergaard, Krista D; Nielsen, Claus H; Christensen, Kent L; Bibby, Bo M; Jensen, Jens D; Jespersen, Bente.

Afiliação

Peters CD; Department of Renal Medicine, Aarhus University Hospital, Denmark.
Kjaergaard KD; Institute of Clinical Medicine, Aarhus University, Denmark.
Nielsen CH; Department of Renal Medicine, Aarhus University Hospital, Denmark.
Christensen KL; Institute of Clinical Medicine, Aarhus University, Denmark.
Bibby BM; Institute for Inflammation Research, Rigshospitalet, Copenhagen, Denmark.
Jensen JD; Department of Cardiology, Aarhus University Hospital, Denmark.
Jespersen B; Department of Biostatistics, Aarhus University, Denmark.

Hemodial Int ; 21(1): 47-62, 2017 01.

Article em En | MEDLINE | ID: mdl-27346437

Assuntos

Bloqueadores do Receptor Tipo 1 de Angiotensina II/uso terapêutico; Compostos de Bifenilo/uso terapêutico; Diálise Renal/métodos; Tetrazóis/uso terapêutico; Biomarcadores/sangue; Método Duplo-Cego; Feminino; Humanos; Irbesartana; Masculino; Pessoa de Meia-Idade; Diálise Renal/efeitos adversos

Palavras-chave

Angiotensin II blockade; cytokines; hemodialysis; inflammation; randomized controlled trial

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetrazóis / Compostos de Bifenilo / Diálise Renal / Bloqueadores do Receptor Tipo 1 de Angiotensina II Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Hemodial Int Assunto da revista: NEFROLOGIA / TERAPEUTICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google